Sarepta Therapeutics, Inc. (United States) holds 0 active US FDA Type II Drug Master Files and 1 inactive and is linked to 1 FDA-registered manufacturing site. 1 FDA enforcement record is linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Sarepta Therapeutics, Inc.: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/sarepta-therapeutics-inc

Overview

Sarepta Therapeutics, Inc. is a medical research and drug development company focused on developing precision genetic medicines to treat rare neuromuscular diseases. With a primary emphasis on Duchenne muscular dystrophy, the company utilizes innovative RNA-based platforms to address unmet medical needs.

Therapeutic areas

Neuromuscular diseasesGenetic disorders

API / Drug Master Files

Sarepta Therapeutics, Inc. holds 0 active (1 total) FDA Type II Drug Master File. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • SRP-2001 DRUG SUBSTANCEInactive2023-02-28

Registered manufacturing sites (1)

Physical sites registered with the US FDA and resolved to Sarepta Therapeutics, Inc., with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

1 FDA enforcement record linked to this company.

  • 4832018-04-12

    Periodic safety report missing ICSR

For suppliers

Is this Sarepta Therapeutics, Inc.?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.